MARKETING PRACTICES OF NON-PBM OWNING COMPANIES SEEKING MARKET SHARE ARE AN AGENCY CONCERN -- FDA's PENDERGAST; PEDIATRIC LABELING INCENTIVES EXAMINED
Executive Summary
FDA is concerned with the marketing responses of pharmaceutical companies that do not have alliances with pharmacy benefit management companies, Deputy Commissioner Mary Pendergast told a joint conference of FDA and PDA (formerly the Parenteral Drug Association) Sept. 19.